Table 2.

Microbiological findings

Characteristic	Colonized
Patients (n, %)	59
VRE (n, %)	22 (37.3)
Enterococcus faecalis (n, %)	0 (0)
Enterococcus faecium (n, %)	22 (100)
ESBL/ ± FQ (n, %)	35 (59.3)
Escherichia coli (n, %)	19 (54.3)
Klebsiella pneumoniae (n, %)	16 (45.7)
MRSA (n, %)	8 (13.6)
CRE (n, %)	1 (1.7)
≥ 2 MDRO (n, %)	6 (10.2)

VRE, vancomycin-resistant Enterococcus faecalis/ faecium; ESBL/ ± FQ, extended-spectrum ß-lactamase phenotype with or without flourquinolone resistance; CRE, carbapenem-resistant Enterobacterales; MRSA, methicillin-resistant S. aureus; MDRO, multidrug-resistant organism